We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
+5.83%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$383B
AUM Growth
+$14.2B
Cap. Flow
-$1.89B
Cap. Flow %
-0.5%
Top 10 Hldgs %
13.31%
Holding
4,419
New
190
Increased
1,733
Reduced
2,081
Closed
173

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$531M
2
KMI icon
Kinder Morgan
KMI
+$496M
3
IBM icon
IBM
IBM
+$253M
4
CA
CA, Inc.
CA
+$213M
5
EL icon
Estee Lauder
EL
+$209M

Sector Composition

Rank Sector Weight
1 Technology 16.01%
2 Financials 13.85%
3 Healthcare 13.68%
4 Industrials 10.26%
5 Consumer Discretionary 8.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOCM
4026
DELISTED
LOCAL CORP COM STK (DE)
LOCM
$61K ﹤0.01%
58,491
+2
+0% +$3
NAII icon
4027
Natural Alternatives International
NAII
$13.6M
$60K ﹤0.01%
11,157
GLDC
4028
DELISTED
GOLDEN ENTERPRISES
GLDC
$60K ﹤0.01%
17,015
LSG
4029
DELISTED
LAKE SHORE GOLD CORP
LSG
$59K ﹤0.01%
86,730
+13,860
+19% +$11.6K
SES
4030
DELISTED
Synthesis Energy Systems Inc.
SES
$58K ﹤0.01%
965
+1
+0.1% +$63
TBRA
4031
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$58K ﹤0.01%
7,153
-115
-2% -$990
AVEO
4032
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$56K ﹤0.01%
6,624
+5
+0.1% +$46
PGEN icon
4033
CALL
Precigen
PGEN
$2.34B
$55K ﹤0.01%
2,106
-1,818
-46% -$39.9K
TOVX icon
4034
Theriva Biologics
TOVX
$10.9M
$54K ﹤0.01%
4
GMO
4035
DELISTED
General Moly, Inc.
GMO
$54K ﹤0.01%
94,869
MCD icon
4036
CALL
McDonald's
MCD
$193B
$52K ﹤0.01%
+550
New +$51.5K
STRR
4037
DELISTED
Star Equity Holdings
STRR
$52K ﹤0.01%
236
NPTN
4038
DELISTED
NEOPHOTONICS CORP
NPTN
$52K ﹤0.01%
15,338
BXC icon
4039
BlueLinx
BXC
$701M
$51K ﹤0.01%
4,412
+2
+0% +$24
SKY icon
4040
Champion Homes
SKY
$5.12B
$51K ﹤0.01%
12,483
+16
+0.1% +$60
AIG icon
4041
CALL
American International
AIG
$39.7B
$50K ﹤0.01%
+900
New +$48.3K
IBIO icon
4042
iBio
IBIO
$70M
$50K ﹤0.01%
+14
New +$74.7K
SEEL
4043
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
TCCO
4044
DELISTED
Technical Communications Corporation
TCCO
$50K ﹤0.01%
10,583
ALXA
4045
DELISTED
Alexza Pharmaceuticals Inc
ALXA
$50K ﹤0.01%
33,445
LINC icon
4046
Lincoln Educational Services
LINC
$974M
$49K ﹤0.01%
17,606
-145,711
-89% -$433K
BSTG
4047
DELISTED
Biostage, Inc. Common Stock
BSTG
$49K ﹤0.01%
15,268
TLOG
4048
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$48K ﹤0.01%
+10,000
New +$44.7K
UQM
4049
DELISTED
UQM Technologies, Inc.
UQM
$47K ﹤0.01%
59,955
HNSN
4050
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$47K ﹤0.01%
8,521
+1
+0% +$8

Similar funds

Bank of New York Mellon's Q4 2014 Portfolio in Review

As of Q4 2014, Bank of New York Mellon held 4,419 positions worth $383B, up 3.9% from $368B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Bank of New York Mellon's Q4 2014 filing shows 190 new, 1,733 increased, 2,081 reduced and 173 closed positions. Its largest new stake was UBS Group: 11,155,329 shares worth $190M. The largest sale was Intel, an estimated $385M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Bank of New York Mellon's largest Q4 2014 buy was UBS Group: 11,155,329 shares worth $190M.
  • Bank of New York Mellon added most to Gilead Sciences in Q4 2014, an estimated $531M increase.
  • Bank of New York Mellon's biggest Q4 2014 reduction was Intel, cutting an estimated $385M.
  • Bank of New York Mellon fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $113M.
  • Bank of New York Mellon's ten largest holdings make up 13% of its $383B portfolio in Q4 2014.
  • Bank of New York Mellon opened 190 new positions and closed 173 in Q4 2014.
  • Bank of New York Mellon's portfolio value rose 3.9% quarter-over-quarter to $383B.

Based on Bank of New York Mellon's 13F filing for Q4 2014, filed 17 Feb 2015.